Biomotion Sciences Ordinary Shares
Price & Volume
Stats
See more52W Range | $0.35-$77.70 |
Market Cap | $2M |
Shares Short | 119,287 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$20.29 |
News
See moreYahoo Finance • 3 months ago
Silexion Therapeutics Announces 1-for-10 Reverse Share Split
Yahoo Finance • 3 months ago
Silexion Therapeutics Posts Wider Q1 Loss, Advances SIL204 Into Phase 2/3 Trials; Stock Up
Yahoo Finance • 3 months ago
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance • 4 months ago
Silexion Therapeutics prices new warrants exercise deal at $0.50 to raise $1M
About
CEO | Mr. Ilan Hadar M.B.A. |
CFO | Ms. Mirit Horenshtein Hadar |
Address | The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |